1,100 results on '"Soucy, Jean-Paul"'
Search Results
2. Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease
3. Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease
4. Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology
5. Neuroimaging in Clinical Geriatric Psychiatry
6. Brain PET Imaging in Small Animals: Tracer Formulation, Data Acquisition, Image Reconstruction, and Data Analysis
7. APOEε4 potentiates amyloid β effects on longitudinal tau pathology
8. The neurophysiological brain-fingerprint of Parkinson’s disease
9. Dosimetry of [18F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans
10. Distribution of [11C]-JNJ-42491293 in the marmoset brain: a positron emission tomography study
11. Lactate’s behavioral switch in the brain: An in-silico model
12. Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
13. Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis
14. Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
15. Intra-individual comparison of 18F-sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial
16. Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease
17. Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer’s disease
18. Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
19. [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
20. Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression
21. PET Imaging in Dementia: Mini-Review and Canadian Perspective for Clinical Use
22. Evaluation of an automated feedback intervention to improve antibiotic prescribing among primary care physicians (OPEN Stewardship): a multinational controlled interrupted time-series study
23. 99m Tc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in Patients With Isolated REM Sleep Behavior Disorder
24. An Evaluation of the Impact of an OPEN Stewardship Generated Feedback Intervention on Antibiotic Prescribing among Primary Care Veterinarians in Canada and Israel
25. Quantification of [11C]ABP688 binding in human brain using cerebellum as reference region: biological interpretation and limitations
26. Normal cognition in Parkinson's disease may involve hippocampal cholinergic compensation: An exploratory PET imaging study with [18F]-FEOBV
27. Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease
28. APOEε4 potentiates the relationship between amyloid-β and tau pathologies
29. Microglial activation and tau propagate jointly across Braak stages
30. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis
31. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
32. First-in-human imaging and kinetic analysis of vesicular acetylcholine transporter density in the heart using [18F]FEOBV PET
33. Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology.
34. Structural white matter properties and cognitive resilience to tau pathology.
35. Public transit mobility as a leading indicator of COVID-19 transmission in 40 cities during the first wave of the pandemic.
36. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
37. Synaptic dysfunction, Tau pathology and Neurodegeneration
38. Amyloid and tau pathology are associated with white matter properties in cognitively unimpaired older adults at risk of AD dementia
39. CSF total tau is more closely associated with synaptic dysfunction than overt neurodegeneration
40. Association of reactive astrogliosis and microglial activation with tau pathology in Alzheimer’s disease
41. Neuroinflammation Exacerbates Irritability and Agitation in Alzheimer’s Disease
42. Mapping the effects of functional and structural network reorganization on the tau‐cognition relationship in Alzheimer’s disease
43. APOEε4 potentiates the effects of Aβ pathology on the deposition of neurofibrillary tangles via tau phosphorylation
44. The role of biofluid markers in predicting near‐term cognitive impairment
45. Plasma p‐tau 181 outperforms FDG‐PET and plasma‐NfL in the diagnosis of biological AD
46. Plasma p-tau 181 outperforms FDG-PET in the early diagnosis of biological AD
47. Increased brain cholinergic innervation in isolated REM sleep behaviour disorder from prodromal multiple system atrophy
48. Potential utility of using both APOEε4 and Aβ positivity to enrich clinical trials of tau‐targeting therapies
49. Microglial Activation Contributes to Neuropsychiatric Dysfunction in Alzheimer’s Disease
50. [18F]MK6240 and [18F]PI2620 autoradiography on postmortem human brain tissue in AD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.